Cancer Nexus Blog

Dohoon Kim, PhD, and team are poisoning cancer cells from the inside. With the help of a UMass Chan Bridge Fund, they aim to develop a drug that blocks a detoxifying enzyme from neutralizing a dangerous metabolite within cancer cells. Without this detoxifying enzyme, the cancer cells will die.

UMass thoracic surgeons perform simulated surgery using a robotic platform to train for an emergency conversion to an open procedure.

A pilot study to develop new bioinformatic tools to identify fusion circRNAs in cancer has received funding from the UMass Cancer Center and PQHS

UMass was selected as one of only a few sites around North America offering a phase I/II clinical trial involving intratumoral injection

Our studies have discovered that the genome (DNA) editing tool known as CRISPR-Cas9 can efficiently induce somatic genome editing in the lungs of adult animals. We designed various delivery vectors that could effectively deliver CRISPR editing components.

We have been working on a pilot research study that uses technology to facilitate effective communication between patients and healthcare providers about lung cancer screening.